Endophthalmitis caused by Staphylococcus epidermidis: In vitro antibiotic susceptibilities and clinical outcomes

Ophthalmic Surgery Lasers and Imaging

Volumn 38, Issue 6, 2007, Pages 446-451

  Miller, Daniel M ^a   Vedula, Anil S ^a   Flynn Jr , Harry W ^a   Miller, Darlene ^a   Scott, Ingrid U ^a   Smiddy, William E ^a   Murray, Timothy G ^a   Venkatraman, Anna S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CEPHALOSPORIN; COTRIMOXAZOLE; GATIFLOXACIN; GENTAMICIN; MOXIFLOXACIN; VANCOMYCIN; ANTIINFECTIVE AGENT; METICILLIN; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CATARACT; CONTROLLED STUDY; ENDOPHTHALMITIS; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; VISUAL ACUITY; BACTERIAL EYE INFECTION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; RETROSPECTIVE STUDY;

AGED; AMIKACIN; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VANCOMYCIN; VISUAL ACUITY;

EID: 38349030926     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20071101-01     Document Type: Article

References (24)

1. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479-1496.
2. Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997;104:261-272.
3. Ormerod LD, Ho DD, Becker LE, et al. Endophthalmitis caused by the coagulase negative staphylococci: 1. Disease spectrum and clinical outcome. Ophthalmology. 1993;100:715-723.
4. Ormerod LD, Becker LE, Cruise RJ, et al. Endophthalmitis caused by the coagulase negative staphylococci: 2. Factors influencing presentation after cataract surgery. Ophthalmology. 1993;100:724-729.
5. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1-17.
6. Endophthalmitis Vitrectomy Study Group. Microbiologic factor and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:830-846.
7. Kangas TA, Greenfield DS, Flynn HW Jr, Parrish RK 2nd, Palmberg P. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology. 1997;104:746-752.
8. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109:985-991.
9. Lieb DF, Scott IU, Flynn HW Jr, Miller D, Feuer WJ. Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes. Ophthalmology. 2003;110:1560-1566.
10. Cohen SM, Flynn HW Jr, Murray TG, Smiddy WE. Endophthalmitis after pars plana vitrectomy. The Post-vitrectomy Endophthalmitis Study Group. Ophthalmology. 1995;102:705-712.
11. Greenfield DS, Suñer IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW Jr. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996;114:943-949.
12. Gedde SJ, Scott IU, Tabandeh H, Luu KKM, Budenz DL, Greenfield DS, Flynn HW Jr. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology. 2001;108:1323-1327.
13. Kim JE, Flynn HW Jr, Rubsamen PE, Murray TG, Davis JL, Smiddy WE. Endophthalmitis in patients with retained lens fragments after phacoemulsification. Ophthalmology. 1996;103:575-578.
14. Eifrig CW, Scott IU, Flynn HW Jr, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004;138:799-802.
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobials Susceptibility Tests for Bacteria That Grow Aerobically, 5th ed. Approved Standard. Villanova, Pennsylvania, National Committee for Clinical Laboratory Standards, 2003. Document M2-A8.
16. Mino de Kaspar H, Hoepfner AS, Engelbert M, et al. Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology. 2001;108:470-478.
17. Benz MS, Scott IU, Flynn HW Jr, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004;137:38-42.
18. Anand AR, Therese KL, Madhavan HN. Spectrum of aetiologic agents of postoperative endophthalmitis and antibiotic sensitivity of bacterial isolates. Indian J Ophthalmol. 2000;48:123-128.
19. Recchia FM, Busbee BG, Pearlman RB, Carvalho-Recchia CA, Ho AC. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol. 2005;123:341-346.
20. Davis JL, Koidou-Tsiligianni A, Pflugfelder SC, Miller D, Flynn HW Jr, Forster RK. Coagulase-negative staphylococcal endophthalmitis: increase in antimicrobial resistance. Ophthalmology. 1988;95:1404-1410.
21. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999;106:1313-1318.
22. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463-466.
23. Gill SR, Fouts DE, Archer GL, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol. 2005;187:2426-2438.
24. Yao Y, Sturdevant DE, Villaruz A, Xu L, Gao Q, Otto M. Factors characterizing Staphylococcus epidermidis invasiveness determined by comparative genomics. Infect Immun. 2005;73:1856-1860.